Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit, diverted, and adulterated drugs entering into the supply chain. Apart from having an end to end visibility and traceability within the supply chain, an effective serialization programs will be a key differentiator and will be a competitive advantage for the pharmaceutical companies. Drug counterfeiting which is not only a global public health risk, but also harm the quality of the product, the integrity of the brand, the economy and even national security. Revenues from the pharma and bio-pharma counterfeit market is estimated to be more than $200 billion. Aligning your anti-counterfeiting strategy with the corporate supply chain strategy should plot a roadmap for implementing anti-counterfeiting measures.
Both industry and governments across the world recognising the importance of implementing product serialization, it becomes obligatory for all entities within the supply chain to comply with federal or state legislations pertaining to the locations in which they operate.
Initiatives focusing on supply chain monitoring, such as mass serialisation, track and trace or hologram tagging, had mixed outcomes, as counterfeiters are agile and have found ways to bypass the steps quickly. Pharmaceutical companies and regulators are still developing techniques to stop them by creating intelligence led brand protection strategy. This also reveals numerous gaps in the governmental and industry efforts to safeguard global pharmaceutical and bio-tech supplies.
Corvus Global Events invites you to 3rd Annual Pharma Supply Chain & Security World 2021 - Supply-chain, Drug Serialization and Anti-Counterfeiting conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference you’ll not only discover innovative technologies, transformation strategies and collaboration methods, but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting.
It gives us a great pleasure to welcoming you to the 3rd Annual Pharma Supply Chain & Security World 2021.
Both industry and governments across the world recognising the importance of implementing product serialization, it becomes obligatory for all entities within the supply chain to comply with federal or state legislations pertaining to the locations in which they operate.
Initiatives focusing on supply chain monitoring, such as mass serialisation, track and trace or hologram tagging, had mixed outcomes, as counterfeiters are agile and have found ways to bypass the steps quickly. Pharmaceutical companies and regulators are still developing techniques to stop them by creating intelligence led brand protection strategy. This also reveals numerous gaps in the governmental and industry efforts to safeguard global pharmaceutical and bio-tech supplies.
Corvus Global Events invites you to 3rd Annual Pharma Supply Chain & Security World 2021 - Supply-chain, Drug Serialization and Anti-Counterfeiting conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference you’ll not only discover innovative technologies, transformation strategies and collaboration methods, but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting.
It gives us a great pleasure to welcoming you to the 3rd Annual Pharma Supply Chain & Security World 2021.
